Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep neuromuscular block in robot-assisted stomach cancer surgery
NCT03937440Completed
- Sponsor
- Yonsei University
- Start
- Jul 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rocuronium in gastric cancer (GC), sponsored by Yonsei University. Primary endpoint: Difference of stress responses at baseline. Started Jul 2019; status: completed.
02
Drugs
rocuronium
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03937440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03937440.